| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |